Large insurers reducing their involvement in the Affordable Care Act health insurance exchanges doesn't necessarily indicate failure, but success is not guaranteed, said Michael E. Chernew, PhD.
Large insurers reducing their involvement in the Affordable Care Act health insurance exchanges doesn't necessarily indicate failure, but success is not guaranteed, said Michael E. Chernew, PhD, the Leonard D. Schaeffer Professor of Health Care Policy and director of the Healthcare Markets and Regulation Lab at Harvard Medical School, as well as co-editor-in-chief of The American Journal of Managed Care.
Transcript (slightly modified)
What is your opinion on the sustainability of the Affordable Care Act with large insurers pulling back on their involvement in the exchanges?
I think it's too early to tell how well the exchanges will stabilize. It's certainly concerning when insurers pull out. But other insurers are expanding. There are some markets that probably have too few carriers to maintain real competition, many of those are rural markets. But there are others—many urban markets you still have vigorous competition on the exchanges.
So insurers, largely, would not be expected to participate on the exchanges that they were losing money, and many of the larger insurers were. So they've opted not to participate. It remains to be seen in the future if they get back in, if the market stabilizes, if there are enough competitors. Right now, we're far from failure, but success isn't guaranteed.
What is the importance of new insurers entering the ACA exchanges as insurers like Aetna and UnitedHealth Group reduce their involvement?
It varies by market, in general. You don't want to have too many carriers, because it makes choice very hard. On the other hand, there are some markets that have too few. So there are selected places—my understanding is that North Carolina and other places—where it would be important to have more competitive insurers potentially as some of the insurers pull out. Others, it's less important.
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More